Clinical Trial Update: The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer

View source ↗

Summary

A completed clinical trial studied the impact of aromatase inhibitors on cardiovascular risk factors in women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Pittsburgh | Conditions: Breast Cancer | Status: COMPLETED